RxDoctor Payments DataLook up a doctor →

Gena Thompson, PA

Physician Assistant · Chattanooga, TNNPI 1811212392

Payments from drug & device makers

$13,070in general payments, 2019–2025

Across 543 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Enterra Medical, Inc.$2K
  • Johnson & Johnson$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$904
  • Takeda Pharmaceuticals U.S.A., Inc.$787
  • Regeneron Healthcare Solutions, Inc.$451
  • plus $5K from 37 others

What the payments were for

  • Travel & lodging$1,1409%
  • Food & beverage$11,74390%
  • Education$1881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,070 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$21,823
Medicare patients
135
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase69$302,048
LinzessLinaclotide167$170,884
RelistorMethylnaltrexone Bromide15$50,860
Lubiprostone141$22,257
TrulancePlecanatide18$11,878
Pantoprazole Sodium567$7,567
Famotidine358$7,086
Dexlansoprazole DrDexlansoprazole24$6,105
ClenpiqSod Picosulf/Mag Ox/Citric Ac35$6,001
Omeprazole302$5,244
CholestyramineCholestyramine (With Sugar)43$4,665
SutabSod Sulf/Pot Chloride/Mag Sulf17$2,787
Ursodiol14$2,686
SuprepSodium, Potassium,mag Sulfates16$1,763
Esomeprazole Magnesium36$1,667

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$3,374$472,932236 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor, Trulance$904$62,73833 claims
Ferring Pharmaceuticals Inc.Clenpiq$115$6,00135 claims
Braintree Laboratories, Inc.Sutab$62$2,78717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →